CERRITOS, Calif., Aug. 15, 2019 /PRNewswire-PRWeb/ -- Dr. Babak Baseri earned his medical
Dr. Babak Baseri has extensive clinical and research experience. Prior to medical school, he was a research scientist at the Department of Biomedical Engineering at Columbia University. During his medical school residency and fellowship, he trained at numerous healthcare systems serving diverse patient populations including the nationally recognized Memorial Sloan Kettering Cancer Center in New York, Hackensack University Medical Center in New Jersey, Veterans Affairs Medical Center in Brooklyn and Kings County Hospital in Brooklyn, New York.
Dr. Baseri has received various awards and certificates of achievements in research during his training. He was inducted into the Alpha Omega Alpha medical honor society and lota Epsilon Alpha international medical honor society. He has multiple publications and poster/abstract presentations in the field of hematology/oncology and biomedical sciences. He remains highly active in clinical studies and continues to publish in his field. His research interests include clinical risk assessments, prognostic and predictor markers, sequencing and timing of cancer therapeutics, cancer prevention, and patient outcomes.
He is fluent in English and Farsi.
American Society of Clinical Oncology (ASCO) American Society of Hematology (ASH) Member of American College of Physicians (ACP) Journal of American Medical Association (JAMA) Alpha Omega Alpha Medical Honor Society
Patient Care Philosophy
"I have had the opportunity to care for diverse patient populations from different socioeconomic backgrounds with a variety of diseases. I understand the importance of not only providing the best medical care possible but also one that is most suitable for an individual patient. Battling illnesses such as cancer can be very difficult and challenging for patients and their families. My goal is to support them in their life journey as they cope with their illnesses, improve their quality of life and reduce their burden of disease, and respect their autonomy and dignity through effective communication and education."
SOURCE The Oncology Institute of Hope and Innovation
Subscribe to our Free Newsletters!